EQUITY ALERT: The M&A Class Action Firm Announces the Investigation of Ayala Pharmaceuticals, Inc.
prnewswire.com
news
2022-10-20 23:14:00

NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Ayala Pharmaceuticals, Inc. (AYLA), relating to its proposed merger with Advaxis, Inc. Under the terms of the agreement, AYLA shareholders are expected to own approximately 62.
